参与多项临床研究。
发表论文多篇。
曾为《中华肿瘤杂志》等杂志审稿。
多次为《肿瘤时讯》、《中国医学论坛报》撰稿。
主要论著：
1.Hua Bai, Zhijie Wang, Keneng Chen, Jun Zhao, Shuhang Wang, Qinghua Zhou, Minglei Zhuo, Tongtong An, Jianchun Duan, Lu Yang, Meina Wu, Zhen Liang, Yuyan Wang1, Xiaozheng Kang, Jie Wang. Influence of Chemotherapy on EGFR Mutation Status for Patients with Non-small Cell Lung Cancer. J Clin Oncol，2012
2.Shuhang wang , Tongtong An, Jie Wang, Jun Zhao, Zhijie Wang, Minglei Zhuo, Hua Bai, Lu Yang, Yan Zhang, Xin Wang, Jianchun Duan, Yuyan Wang, Qingzhi Guo, Meina Wu. Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced NSCLC. Clin Cancer Res 2010, 15,16(4):1324-1330
3.Zhuo Ming-lei, Wang Jie. Personalized therapy with EGFR-TKI in non-small cell lung cancer: consensus and controversy. Journal of the HONG KONG College of Radiologists. 2010, 13(3), 10-16
4.Zhuo Ming-lei, WU Mei-na, ZHAO Jun, Sonya Wei Song, BAI Hua, WANG Shu-hang, YANG Lu, AN Tong-tong, WANG Xin, DUAN Jian-chun, WANG Yu-yan, GUO Qing-zhi, LIU Xu-yi, LIU Ning-hong, WANG Jie Epidermal growth factor receptor genotype in plasma DNA and outcome of chemotherapy in the Chinese patients with advanced non-small cell lung cancer. Chinese Medical Journal 2011;124(21) :3510-3514
5.Zhijie Wang, Xuchao Zhang, Hua Bai, Jun Zhao, Minglei Zhuo, Tongtong An, Jianchun Duan, Lu Yang, Meina Wu, Shuhang Wang, Yuyan Wang, Yilong Wu and Jie Wang. NSCLC patients with EML4-ALK rearrangement cannot benefit from EGFR-TKI. Oncology, 2012.
